C. Tasci Et Al. , "The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis," ONCOTARGETS AND THERAPY , vol.5, pp.385-390, 2012
Tasci, C. Et Al. 2012. The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis. ONCOTARGETS AND THERAPY , vol.5 , 385-390.
Tasci, C., Ozkaya, S., Ozkara, B., Tozkoparan, E., Ozkan, M., Karadurmus, N., ... Serdar, M. A.(2012). The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis. ONCOTARGETS AND THERAPY , vol.5, 385-390.
Tasci, Canturk Et Al. "The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis," ONCOTARGETS AND THERAPY , vol.5, 385-390, 2012
Tasci, Canturk Et Al. "The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis." ONCOTARGETS AND THERAPY , vol.5, pp.385-390, 2012
Tasci, C. Et Al. (2012) . "The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis." ONCOTARGETS AND THERAPY , vol.5, pp.385-390.
@article{article, author={Canturk Tasci Et Al. }, title={The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis}, journal={ONCOTARGETS AND THERAPY}, year=2012, pages={385-390} }